Dipeptidyl-peptidase-4 inhibitor, alogliptin, attenuates arterial inflammation and neointimal formation after injury in low-density lipoprotein (LDL) receptor-deficient mice. [electronic resource]
Producer: 20160301Description: e001469 p. digitalISSN:- 2047-9980
- Actins -- metabolism
- Animals
- Anti-Inflammatory Agents -- pharmacology
- Arteritis -- enzymology
- Atherosclerosis -- enzymology
- Biomarkers -- blood
- Blood Glucose -- drug effects
- Cell Proliferation -- drug effects
- Chemokine CCL2 -- metabolism
- Cholesterol -- blood
- Dipeptidyl Peptidase 4 -- metabolism
- Dipeptidyl-Peptidase IV Inhibitors -- pharmacology
- Disease Models, Animal
- Femoral Artery -- drug effects
- Glucagon-Like Peptide 1 -- blood
- Inflammation Mediators -- metabolism
- Interleukin-1beta -- metabolism
- Male
- Mice, Knockout
- NF-kappa B -- metabolism
- Neointima
- Phosphorylation
- Piperidines -- pharmacology
- Proliferating Cell Nuclear Antigen -- metabolism
- Receptors, LDL -- deficiency
- Tumor Necrosis Factor-alpha -- metabolism
- Uracil -- analogs & derivatives
- Vascular System Injuries -- drug therapy
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.